Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-β3 (TGFβ3) and altered responses to the antiproliferative effects of TGFβ

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 913-920

  Lee, Byung Seok ^a   Nowak, Romana A ^b,c  

^a Yonsei University College of Medicine   (South Korea)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CYTOKINE PRODUCTION; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MYOMETRIUM; NORTHERN BLOTTING; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TUMOR GROWTH; UTERUS MYOMA;

CELL DIVISION; CELLS, CULTURED; FEMALE; HUMANS; LEIOMYOMA; MUSCLE, SMOOTH; MYOMETRIUM; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0035093153     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.2.913     Document Type: Article

References (40)

1. Uterine leiomyomata: Etiology, symptomatology and management
2. Uterine fibroids: A clinical review
3. Uterine leiomyomas: The somatic mutation theory
4. Hysterectomy in the United States, 1988-1990
5. Estradiol and progesterone binding in uterine leiomyoma and in normal uterine tissues
6. Unconjugated steroids in leiomyomas and tumor-bearing myometrium
7. Mitotic activity in uterine leiomyomas during the menstrual cycle
8. Steroidal treatment of leiomyomas: Preoperative and long term medical therapy
9. Progesterone: A critical role in the pathogenesis of uterine myomas
10. Autocrine and paracrine growth regulation of breast cancer
11. Metabolism and effects of epidermal growth factor and their related growth factors in mammals
12. The transforming growth factor-β family
13. The cell biology of transforming growth factor β
14. TGF-β receptors and TGF-β binding proteoglycans: Recent progress in identifying their functional properties
15. Receptors for the TGF-β family
16. TGFβ signaling: Receptors, transducers, and MAD proteins
17. 125I-TGF-β1 binding sites
18. 125I-TGF-β1 binding sites
19. The expression of transforming growth factor-βs and TGF-β receptor mRNA and protein and the effect of TGF-βs on human myometrial smooth muscle cells in vitro
20. Regulation by estrogen (E) of the transforming growth factor-β(TGF-β) system in uterine leiomyomas
21. Suppression of transforming growth factor-β and TGFβ receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy
22. Production of prolactin by smooth muscle cells cultured from uterine fibroid tumors
23. Transforming growth factor beta in tissue fibrosis
24. Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas
25. Fibroblast and transforming growth factors in endothelial wound healing in vitro
26. Chronic inflammation, PDGF, TGFβ, and smooth muscle cell proliferation
27. Expression of transforming growth factors β1, 2, and 3 following vascular injury
28. Mechanism of activation of the TGF-β receptors
29. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions
30. Regional variability in the time course of TGF-β1 expression, cellular proliferation and extracellular matrix expansion following arterial injury
31. Transforming growth factor-β inhibits human vascular smooth muscle cell growth and migration
32. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-β in vascular smooth muscle cells
33. Transforming growth factor beta 1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats
34. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells
35. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions
36. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix
37. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy
38. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells
39. Immunohistochemical detection of transforming growth factor-β1 in fibrotic liver diseases
40. Altered expression of small proteoglycans, collagen, and transforming growth factor-β1 in developing bleomycin-induced pulmonary fibrosis in rats